1. Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses. (March 2018) Authors: Burke, Patrick W.; Aldoss, Ibrahim; Lunning, Matthew A.; Devlin, Sean M.; Tallman, Martin S.; Pullarkat, Vinod; Mohrbacher, Ann M.; Douer, Dan Journal: Leukemia research Issue: Volume 66(2018) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia. Issue 10 (10th July 2019) Authors: Aldoss, Ibrahim; Yang, Dongyun; Pillai, Raju; Sanchez, James F.; Mei, Matthew; Aribi, Ahmed; Ali, Haris; Sandhu, Karamjeet; Al Malki, Monzr M.; Salhotra, Amandeep; Khaled, Samer; Sun, Weili; O'Donnell, Margaret; Snyder, David; Nakamura, Ryotaro; Stein, Anthony S.; Forman, Stephen J.; Marcucci, Gu... Journal: American journal of hematology Issue: Volume 94:Issue 10(2019:Oct.) Page Start: E253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The feasibility of venetoclax and decitabine in therapy-related acute myeloid leukemia with concurrent advanced non-hematological malignancies. (September 2019) Authors: Otoukesh, Salman; Salhotra, Amandeep; Marcucci, Guido; Forman, Stephen J; Pullarkat, Vinod; Aldoss, Ibrahim Journal: Leukemia research Issue: Volume 84(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Toxicity profile of repeated doses of PEG‐asparaginase incorporated into a pediatric‐type regimen for adult acute lymphoblastic leukemia. (25th June 2015) Authors: Aldoss, Ibrahim; Douer, Dan; Behrendt, Carolyn E.; Chaudhary, Preeti; Mohrbacher, Ann; Vrona, Janice; Pullarkat, Vinod Journal: European journal of haematology Issue: Volume 96:Number 4(2016:Apr.) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse‐free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia. (23rd April 2019) Authors: Chang, Jeremy; Douer, Dan; Aldoss, Ibrahim; Vahdani, Golnaz; Jeong, Ah‐Reum; Ghaznavi, Zunera; Zhang, Sherry; Yaghmour, George; Lee, Kum‐Ja; Weissman, Ashley; Akhtari, Mojtaba Journal: Cancer medicine Issue: Volume 8:Number 6(2019:Jun.) Page Start: 2832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with NUP214-ABL1. Issue 11 (19th September 2019) Authors: Aldoss, Ibrahim; Pullarkat, Vinod Journal: Leukemia & lymphoma Issue: Volume 60:Issue 11(2019) Page Start: 2832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Donor derived leukemia in allogeneic transplantation. Issue 12 (15th October 2021) Authors: Aldoss, Ibrahim; Clark, Mary; Marcucci, Guido; Forman, Stephen J. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 12(2021) Page Start: 2823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Will immunotherapy lead to a breakthrough in the treatment of older adults with ALL?. Issue 4 (December 2021) Authors: Aldoss, Ibrahim; Advani, Anjali; Pullarkat, Vinod Journal: Baillière's best practice and research in clinical haematology Issue: Volume 34:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia. Issue 7 (1st December 2020) Authors: Badar, Talha; Szabo, Aniko; Dinner, Shira; Liedtke, Michaela; Burkart, Madelyn; Shallis, Rory M.; Yurkiewicz, Ilana R.; Kuo, Eric; Khan, Muhammad Ali; Balasubramanian, Suresh; Yang, Jay; Hefazi, Mehrdad; Podoltsev, Nikolai; Patel, Anand; Curran, Emily; Wang, Amy; Arslan, Shukaib; Aldoss, Ibrahim;... Journal: Cancer Issue: Volume 127:Issue 7(2021) Page Start: 1039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantation. Issue 5 (16th April 2022) Authors: Salhotra, Amandeep; Yang, Dongyun; Mokhtari, Sally; Hui, Susanta; Al Malki, Monzr M.; Armenian, Saro; Sigala, Brianna; Aldoss, Ibrahim; Pullarkat, Vinod; Forman, Stephen; Marcucci, Guido; Nakamura, Ryotaro; Artz, Andrew; Wong, Jeffery; Stein, Anthony Journal: Leukemia & lymphoma Issue: Volume 63:Issue 5(2022) Page Start: 1220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗